The Pharmaceuticals Division focuses on prescription drugs for the therapeutic areas of cardiology, oncology, gynecology, hematology and ophthalmology. With its innovative pharmaceutical products, Bayer seeks to achieve a significant therapeutic benefit for patients while at the same time satisfying the growing requirements of physicians and health insurers. The Pharmaceuticals division in China is headquartered in Beijing with facilities in Beijing and Guangzhou. In anticipation of increasing product demand in China, Bayer invested EUR 100 million to significantly increase the production capacity of its Beijing plant. The capacity extension is designed to ensure a reliable supply of high-quality products to meet the Chinese market’s demand for pharmaceutical products, including the company’s cardiovascular and anti-diabetes products. The Pharmaceuticals Division’s Radiology business is a world-well-known diagnostic imaging solutions provider. In the field of Radiology, Bayer provides solution with imaging contrast media, injection devices and informatics in China.
Consumer Health Division
Bayer’s Consumer Health Division is an important player in the global consumer health marketplace. It operates in more than 100 countries and maintains several manufacturing and research-and-development (R&D) sites.
Crop Science Division
The Crop Science Division, a world-well-known crop protection solution provider, is committed to contributing to a sustainable development of agriculture by introducing innovation into the market. With a highly efficient and innovative portfolio, complete technical services and strong collaborations with local partners, the Crop Science Division China is aligned with the Chinese government’s efforts to modernize Chinese agriculture and dedicated to help farmers improve plant health, get better yields and gain more benefits.